Aims Because ceramide accumulates in several forms of cardiovascular disease and ceramideinduced apoptosis may involve the volume-sensitive Cl − current, I Cl,swell , we assessed whether ceramide activates I Cl,swell .
Introduction
Volume-sensitive Cl − current, I Cl,swell , is elicited in cardiac myocytes by osmotic swelling, hydrostatic inflation, β1 integrin stretch, and in several models of cardiac disease. In turn, I Cl,swell modulates cardiac electrical activity, cell volume, apoptosis, and is implicated in ischemic preconditioning. [1] [2] [3] Regulation of I Cl,swell is complex and involves a number of signaling pathways. Recently, reactive oxygen species (ROS) were identified as a downstream effector, and exogenous H 2 O 2 elicits I Cl,swell in cardiomyocytes [4] [5] [6] and other cells. [7] [8] [9] Upstream signaling molecules include Src family kinases, 10-12 focal adhesion kinase, 12,13 protein tyrosine kinase, 14 angiotensin II (Ang II), 4, 6 epidermal growth factor receptor (EGFR) kinase, 11 and phosphoinositide 3-kinase (PI-3K). 5, 6 Protein kinase C (PKC) also is implicated, although its role is controversial because it appears to inhibit 15 or activate I Cl,swell .
15,16
Many of the signaling cascades that activate I Cl,swell overlap those involved in sphingolipid signaling, [17] [18] [19] raising the possibility that certain sphingolipids might regulate I Cl,swell . Sphingolipids are a class of phospholipids defined by the presence of an amide-linked fatty acid, a free hydroxyl group at position three, and a trans double bond between carbons four and five. Initially sphingolipids were considered membrane structural components without further function. More recently, sphingolipids, specifically ceramide and sphingosine, were recognized as bioactive molecules that participate in a number of signaling cascades and mediate apoptosis, mitogenesis, and other cellular processes. Alterations in sphingolipid metabolism are implicated in cardiovascular diseases, including congestive heart failure, atherosclerosis, and ischemia/reperfusion injury. 
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Statistics
Summary data are reported as mean ± SEM; n denotes the number of cells. Mean currents are expressed as current density (pA/pF), and selected paired comparisons are expressed as a percentage or as intervention-induced difference currents. Statistical analysis was executed using SigmaStat 3.11 (Systat). Except as noted, a one-way or one-way repeated measures ANOVA was performed followed by a Student-Newman-Keuls test. P<0.05 was taken as significant. Non-linear curve fits were done in SigmaPlot 10.0 (Systat). Alterations in membrane curvature due to asymmetric insertion of amphipaths into the plasmalemma outer or inner leaflets mimic changes in cell volume and activate I Cl,swell . 30 To exclude the possibility that C 2 -Cer activated I Cl,swell via alteration of membrane curvature or other non-specific mechanisms, we used dihydro-C 2 -ceramide (C 2 -H 2 Cer), a C 2 -Cer analogue that is inactive in ceramide signaling 31 but should exert similar mechanical effects on membranes. As depicted in Figure 3 , C 2 -H 2 Cer failed to activate current above control (n = 6, P = 0.94). To verify the presence of I Cl,swell in cells unresponsive to C 2 -H 2 Cer, C 2 -Cer was then added in 4 experiments. C 2 -Cer evoked I Cl,swell in each of these previously unresponsive cells (n = 4, P < 0.01). Activation by C 2 -Cer but not C 2 -H 2 Cer suggests I Cl,swell was elicited via normal ceramide pathways rather than by a non-specific mechanism.
Results
Exogenous ceramide activates a Cl
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Endogenous ceramide generation is sufficient to activate I Cl,swell
Bacterial SMase is a neutral, Mg 2+ -dependent enzyme that acts specifically at the plasmalemma to convert sphingomyelin to long-chain ceramides that are native to the cell.
Bacterial SMase (0.03 U/mL, 15-18 min), like exogenous C 2 -Cer, evoked an outwardly rectifying Cl − current in >90% of cells tested, and current at +60 mV increased by 1.01 ± 0.05 pA/pF (n = 75, P < 0.001), from 1.22 ± 0.07 to 2.23 ± 0.10 pA/pF ( Figure 4A,B) . SMase- Two blockers of I Cl,swell inhibited bacterial SMase-induced current. DCPIB suppressed 78 ± 6% (10 µM, n = 7, P < 0.01) of the current, and the remaining current was not significantly different than control ( Figure 4B ). Increasing DCPIB to 30 µM did not reduce the SMaseinduced current further (81 ± 6%; n = 4, P = 0.86 vs 10 µM DCPIB). Tamoxifen (10 µM, 5-8 min) also was effective in blocking the SMase-induced Cl − current ( Figure 5 ); it decreased current by 116 ± 16% at + 60 mV (n = 5, P < 0.01). Block of SMase-induced current by DCPIB and tamoxifen confirm its attribution to I Cl,swell .
The volume-sensitivity of Cl − current elicited by bacterial SMase was tested by exposure to hyperosmotic (1.5T) bathing solution in the continued presence of SMase ( Figure 6 ). Cell shrinkage for 15 min inhibited SMase-induced current by 43 ± 8% (n = 6, P < 0.02), from 1.88 ± 0.20 to 1.41 ± 0.14 pA/pF at +60 mV ( Figure 6B) . SMase-induced current in 1.5T bath solution remained, however, significantly greater than control (n = 6, P < 0.02). Partial inhibition by by guest on May 3, 2016
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ROS mediate bacterial SMase-induced activation of I Cl,swell
Previously we demonstrated that H 2 O 2 is a downstream mediator of I Cl,swell activation and exogenous H 2 O 2 elicits I Cl,swell even under hyperosmotic conditions. 4, 6 As shown in Figure 7 , ebselen (20 µM, 5 min), a cell-permeable glutathione peroxidase mimetic that converts H 2 O 2 to H 2 O, inhibited SMase-induced Cl − current by 124 ± 39% (n = 5, P < 0.01) from 2.46 ± 0.43 pA/pF to 1.56 ± 0.33 pA/pF at +60 mV. There was no difference in Cl − currents under control conditions (1.59 ± 0.55 pA/pF) and after addition of ebselen (P = 0.87). This demonstrates that the SMase-induced Cl − current is mediated by ROS. Figure 8 compares the time course of activation of I Cl,swell by C 2 -Cer and bacterial SMase.
Differences in time course of activation due to exogenous and endogenous ceramide
The C 2 -Cer-induced difference current was fit by a single exponential function with a time constant of 6.4 ± 1.6 min (R 2 = 0.93, n = 11), equivalent to a t 1/2 of 4.8 ± 1.2 min. In contrast, SMase-induced difference current was fit by a sigmoid function with a t 1/2 of 9.3 ± 0.6 min (R 2 = 0.99, n = 10). The magnitude of the current turned on at +60 mV by C 2 -Cer, bacterial SMase, and osmotic swelling (i.e., test − control) also were compared. The C 2 -Cer-induced current (0.70 ± 0.09 pA/pF; n = 14) was significantly different than that evoked by bacterial SMase (1.01 ± 0.05 pA/pF; n = 75, P < 0.02) or by hypoosmotic cell swelling in 0.7T bath solution (1.22 ± 0.17 pA/pF, data not shown; n = 6, P < 0.05), whereas the SMase-and swelling-induced currents were indistinguishable (P = 0.24).
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Discussion
Exogenous C 2 -Cer and endogenous long-chain ceramides generated by bacterial SMase activated currents that reversed near E Cl , exhibited outward rectification in physiological and symmetrical Cl − gradients, were partially inhibited by hyperosmotic shrinkage, and were suppressed by the ROS scavenger ebselen. These biophysical features matched those of volumesensitive I Cl,swell , 1, 3, 30 and ROS are required for I Cl,swell activity in heart and other tissues. [4] [5] [6] [7] [8] [9] Additionally, block by DCPIB and tamoxifen strongly implicated I Cl,swell . Tamoxifen 
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Amplification by a signaling cascade may contribute to the strong concentration-dependence of current activation. In cardiomyocytes, ROS produced by NADPH oxidase [4] [5] [6] and mitochondria 42 are essential downstream effectors of I Cl,swell activation by osmotic swelling, integrin stretch and growth factors, and exogenous H 2 O 2 elicits I Cl,swell in cardiomyocytes and other tissues. 7, 8 Ceramides also produces ROS. For example, apoptosis triggered by ceramide is accompanied by mitochondrial ROS production, 18, 43 and ceramide is involved in NADPH oxidase activation in rat mesangial and bovine coronary artery smooth muscle cells. 44, 45 Native ceramides generated by bacterial SMase may not be the ultimate sphingolipid mediator of I Cl,swell . Both ceramide and its metabolite, S1P, are potent lipid second messengers, often with opposing effects on signaling and a cell's fate via the ceramide/S1P rheostat. 17, 19 In contrast, metabolites are unlikely to be required to explain the action of synthetic C 2 -Cer because it does not undergo metabolism by the cellular ceramide pathway 46 .
I Cl,swell is persistently activated in models of dilated cardiomyopathy 1 and is involved in the apoptotic volume decrease (AVD) 7, 8 that precedes apoptotic cell death in normal development, ischemia, or heart failure. The sphingomyelin/ceramide pathway is activated in vivo during ischemia/reperfusion 20, 47, 48 and heart failure 20, 49, 50 , and the oxidation of sphingolipids is implicated in atherosclerotic plaque formation. 18 The data presented here shows a link between intracardiac ceramide accumulation and I Cl,swell activation that may be important for understanding these cardiovascular disease states. Because I Cl,swell outwardly rectifies, its activation tends to shorten action potential duration and depolarize resting membrane potential.
Nevertheless, effects on other ion channels must be assessed to evaluate the consequences of ceramide accumulation on cardiac electrophysiology. 
